Zoetis Inc. (ZTS) Financials

ZTS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 14.3 billion 9.3 billion
2023-09-30 14.1 billion 9.0 billion
2023-06-30 13.7 billion 9.1 billion
2023-03-31 13.8 billion 9.3 billion

ZTS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 699.0 million 17.0 million
2023-09-30 579.0 million 17.0 million
2023-06-30 17.0 million 17.0 million
2023-03-31 326.0 million 9.0 million

ZTS Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 525.0 million
2023-09-30 596.0 million
2023-06-30 670.0 million
2023-03-31 551.0 million

ZTS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 2.0 billion - 188.0 million
2023-09-30 1.8 billion 6.6 billion 191.0 million
2023-06-30 1.7 billion 6.6 billion 188.0 million
2023-03-31 2.1 billion 6.6 billion 180.0 million

ZTS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 460.1 million
2023-09-30 461.4 million
2023-06-30 462.9 million
2023-03-31 464.6 million

ZTS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 198.0 million 174.0 million 565.0 million -
2023-09-30 145.0 million 152.0 million 525.0 million -
2023-06-30 166.0 million 146.0 million 556.0 million -
2023-03-31 223.0 million 142.0 million 505.0 million -

ZTS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.2 billion 765.0 million
2023-09-30 2.2 billion 638.0 million
2023-06-30 2.2 billion 607.0 million
2023-03-31 2.0 billion 588.0 million

ZTS

List: Contenders

Price: $150.88

52 week price:
145.54
201.92

Dividend Yield: 0.01%

5-year range yield:
0.01%
0.96%

Forward Dividend Yield: 1.16%

Payout Ratio: 35.19%

Payout Ratio Range:
16.70%
37.49%

Dividend Per Share: 1.73 USD

Earnings Per Share: 5.07 USD

P/E Ratio: 38.08

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 1.6 million

Ebitda: 543.0 million

Market Capitalization: 68.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 12

DGR3: 18.80%

DGR5: 19.52%

DGR10: 16.63%

Links: